Becton Dickinson Net Income 2006-2018 | BDX

Becton Dickinson annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Becton Dickinson net income for the quarter ending September 30, 2018 was $-0.173B, a 159.86% decline year-over-year.
  • Becton Dickinson net income for the twelve months ending September 30, 2018 was $159M, a 84.56% decline year-over-year.
  • Becton Dickinson annual net income for 2018 was $0.159B, a 84.56% decline from 2017.
  • Becton Dickinson annual net income for 2017 was $1.03B, a 5.53% increase from 2016.
  • Becton Dickinson annual net income for 2016 was $0.976B, a 40.43% increase from 2015.
Becton Dickinson Annual Net Income
(Millions of US $)
2018 $159
2017 $1,030
2016 $976
2015 $695
2014 $1,185
2013 $1,293
2012 $1,170
2011 $1,271
2010 $1,318
2009 $1,232
2008 $1,127
2007 $890
2006 $752
2005 $722
Becton Dickinson Quarterly Net Income
(Millions of US $)
Q4 2018 $-173
Q3 2018 $556
Q2 2018 $-50
Q1 2017 $-174
Q4 2017 $289
Q3 2017 $-165
Q2 2017 $344
Q1 2016 $562
Q4 2016 $19
Q3 2016 $390
Q2 2016 $338
Q1 2015 $229
Q4 2015 $181
Q3 2015 $62
Q2 2015 $216
Q1 2014 $236
Q4 2014 $301
Q3 2014 $326
Q2 2014 $287
Q1 2013 $271
Q4 2013 $90
Q3 2013 $302
Q2 2013 $276
Q1 2012 $625
Q4 2012 $289
Q3 2012 $327
Q2 2012 $291
Q1 2011 $263
Q4 2011 $300
Q3 2011 $343
Q2 2011 $312
Q1 2010 $316
Q4 2010 $397
Q3 2010 $307
Q2 2010 $298
Q1 2009 $316
Q4 2009 $317
Q3 2009 $341
Q2 2009 $261
Q1 2008 $312
Q4 2008 $282
Q3 2008 $297
Q2 2008 $276
Q1 2007 $272
Q4 2007 $260
Q3 2007 $245
Q2 2007 $243
Q1 2006 $143
Q4 2006 $174
Q3 2006 $206
Q2 2006 $154
Q1 2005 $218
Q4 2005 $149
Q3 2005 $190
Q2 2005 $188
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $65.839B $15.983B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $24.205B 9.25
AmerisourceBergen (ABC) United States $19.202B 13.70
Align Technology (ALGN) United States $18.029B 46.00
Laboratory Of America Holdings (LH) United States $16.578B 15.00
Cardinal Health (CAH) United States $16.524B 11.09
Henry Schein (HSIC) United States $13.120B 21.57
Cooper (COO) United States $13.024B 23.45
DENTSPLY SIRONA (XRAY) United States $8.279B 16.53
West Pharmaceutical Services (WST) United States $8.159B 40.49
Merit Medical Systems (MMSI) United States $3.360B 39.79
Patterson (PDCO) United States $2.427B 17.06
CONMED (CNMD) United States $1.929B 32.05
STAAR Surgical (STAA) United States $1.784B 183.77
Atrion (ATRI) United States $1.343B 38.40
Antares Pharma (ATRS) United States $0.532B 0.00
Invacare (IVC) United States $0.189B 0.00
Lifevantage (LFVN) United States $0.161B 22.84
Endologix (ELGX) United States $0.106B 0.00
Pro-Dex (PDEX) United States $0.061B 27.17
Aceto (ACET) United States $0.055B 0.00
Biolase (BIOL) United States $0.027B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.019B 0.00